Correlation Between Blood Cadmium Levels and Platelet Characteristics, As Well As Their Impact on Susceptibility to Coronary Heart Disease: Findings from NHANES 2005-2018 Data

被引:2
作者
Ci, Jichen [1 ]
Zhai, Yuze [2 ]
Wang, Benjun [3 ]
Han, Weiwei [3 ]
Yu, Bianfang [3 ]
An, Fan [2 ]
机构
[1] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, 16369 Jingshi Rd, Jinan 250000, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Clin Med Coll 1, 16369 Jingshi Rd, Jinan 250000, Shandong, Peoples R China
[3] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Anorectal Surg, 16369 Jingshi Rd, Jinan 250000, Shandong, Peoples R China
关键词
Blood cadmium; Platelet count; Mean platelet volume; Coronary heart disease; ARTERY-DISEASE; ASPIRIN; RISK; RIVAROXABAN; VOLUME;
D O I
10.1007/s12012-024-09840-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Investigating the correlation between blood cadmium levels, platelet characteristics, and susceptibility to coronary heart disease (CHD). Utilized NHANES 2005-2018 data with covariates such as age, sex, race, marital status, and socio-economic status. Blood cadmium served as the independent variable, while platelet count (PC) and mean platelet volume (MPV) were dependent variables. The average age of the participants was 68.77 +/- 11.03 years, and 67.4% of them were male. The mean values for WBC, MPV, PC, and blood cadmium were 7.53 +/- 3.36 x 103 cells/mu L, 11.33 +/- 0.27fL, 57.61 +/- 5.34 x 103 cells/mu L, and 2.58 +/- 0.61 mu g/L, respectively. Adjusting for other variables revealed increased MPV and PC with rising blood cadmium levels in cardiac patients, indicating a higher risk of CHD in those with elevated blood cadmium. The average age of the participants was 68.77 +/- 11.03 years, and 67.4% of them were male. The mean values for WBC, MPV, PC, and blood cadmium were 7.53 +/- 3.36 x 103 cells/mu L, 11.33 +/- 0.27fL, 57.61 +/- 5.34 x 103 cells/mu L, and 2.58 +/- 0.61 mu g/L, respectively. Adjusting for other variables revealed increased MPV and PC with rising blood cadmium levels in cardiac patients, indicating a higher risk of CHD in those with elevated blood cadmium. This study enhances understanding of how cadmium impacts platelet characteristics, contributing to increased CHD risk, providing insights for primary prevention strategies.
引用
收藏
页码:335 / 344
页数:10
相关论文
共 37 条
[1]   Atherosclerosis: Recent developments [J].
Bjoerkegren, Johan L. M. ;
Lusis, Aldons J. .
CELL, 2022, 185 (10) :1630-1645
[2]   Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical Trial [J].
Blumenthal, James A. ;
Smith, Patrick J. ;
Jiang, Wei ;
Hinderliter, Alan ;
Watkins, Lana L. ;
Hoffman, Benson M. ;
Kraus, William E. ;
Liao, Lawrence ;
Davidson, Jonathan ;
Sherwood, Andrew .
JAMA PSYCHIATRY, 2021, 78 (11) :1270-1278
[3]   The use of platelet indices, plateletcrit, mean platelet volume and platelet distribution width in emergency non-traumatic abdominal surgery: a systematic review [J].
Budak, Yasemin Ustundag ;
Polat, Murat ;
Huysal, Kagan .
BIOCHEMIA MEDICA, 2016, 26 (02) :178-193
[4]   EFFECTS OF CADMIUM ON PLATELET THROMBOXANE AND VASCULAR PROSTACYCLIN PRODUCTION [J].
CAPRINO, L ;
DOLCI, N ;
TOGNA, G ;
VILLA, P ;
BUCCI, R ;
CARUNCHIO, V .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1982, 65 (01) :185-188
[5]  
Centers for Disease Control and Prevention [CDC], 2022, NCHS Research Ethics Review Board Approval
[6]  
Centers for Disease Control and Prevention (US), 2022, MODULE 3 WEIGHTING
[7]   Data Analysis Using R Programming [J].
Chan, Bertram K. C. .
BIOSTATISTICS FOR HUMAN GENETIC EPIDEMIOLOGY, 2018, 1082 :47-122
[8]   Combined Effect of Blood Cadmium and Lead Levels on Coronary Heart Disease Prediction Risk in Korean Men [J].
Cho, Hye-Min ;
Cho, Doo-Yeoun ;
Kim, Min-Young ;
Yang, Sung-Won ;
Seo, Young-Seok ;
Kim, Kyu-Nam .
ANGIOLOGY, 2016, 67 (06) :582-586
[9]   Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial [J].
Connolly, Stuart J. ;
Eikelboom, John W. ;
Bosch, Jackie ;
Dagenais, Gilles ;
Dyal, Leanne ;
Lanas, Fernando ;
Metsarinne, Kaj ;
O'Donnell, Martin ;
Dans, Anthony L. ;
Ha, Jong-Won ;
Parkhomenko, Alexandr N. ;
Avezum, Alvaro A. ;
Lonn, Eva ;
Liu Lisheng ;
Torp-Pedersen, Christian ;
Widimsky, Petr ;
Maggioni, Aldo P. ;
Felix, Camilo ;
Keltai, Katalin ;
Hori, Masatsugu ;
Yusoff, Khalid ;
Guzik, Tomasz J. ;
Bhatt, Deepak L. ;
Branch, Kelley R. H. ;
Bruns, Nancy Cook ;
Berkowitz, Scott D. ;
Anand, Sonia S. ;
Varigos, John D. ;
Fox, Keith A. A. ;
Yusuf, Salim .
LANCET, 2018, 391 (10117) :205-218
[10]   Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease [J].
Eikelboom, John W. ;
Bhatt, Deepak L. ;
Fox, Keith A. A. ;
Bosch, Jacqueline ;
Connolly, Stuart J. ;
Anand, Sonia S. ;
Avezum, Alvaro ;
Berkowitz, Scott D. ;
Branch, Kelley R. H. ;
Dagenais, Gilles R. ;
Felix, Camilo ;
Guzik, Tomasz J. ;
Hart, Robert G. ;
Maggioni, Aldo P. ;
Muehlhofer, Eva ;
Sharma, Mukul ;
Shestakovska, Olga ;
Yusuf, Salim .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (01) :14-23